You are here

Article Text

Article menu
Download PDFPDF
DTB commentary
Use of short-acting beta agonists in the treatment of asthma across five European countries
  1. Pavlou Panagiotis1,
  2. Jo Congleton2
  1. 1 Clinical Pharmacology, St George's University of London, London, UK
  2. 2 Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
  1. Correspondence to Dr Jo Congleton, Brighton and Sussex University Hospitals NHS Trust, Brighton, BN2 5BE, UK; jo.congleton{at}nhs.net

Abstract

Commentary on: Janson C, Menzies-Gow A, Nan C, et al. SABINA: an overview of short-acting β2-agonist use in asthma in European countries. Adv Ther. 2020;37:1124–35.

Series co-ordinator: Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George’s, University of London, UK

  • asthma
  • therapeutics

https://doi.org/10.1136/dtb.2021.000067

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; internally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.